{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:46:32Z","timestamp":1791009992461,"version":"4.1.0"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"NSFC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.addr.2024.115304","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T22:30:04Z","timestamp":1712615404000},"page":"115304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery"],"prefix":"10.1016","volume":"209","author":[{"given":"Yisi","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7067-8915","authenticated-orcid":false,"given":"Yongzhuo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wufa","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2024.115304_b0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrd4608","article-title":"From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity","volume":"14","author":"Trevaskis","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2024.115304_b0010","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115304_b0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1126\/science.aax4063","article-title":"Biological functions of lymphatic vessels","volume":"369","author":"Petrova","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.addr.2024.115304_b0020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrd2197","article-title":"Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs","volume":"6","author":"Porter","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2024.115304_b0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fphar.2022.887402","article-title":"Targeting lymphatics for nanoparticle drug delivery","volume":"13","author":"McCright","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2024.115304_b0030","doi-asserted-by":"crossref","first-page":"11817","DOI":"10.1021\/acsnano.3c02985","article-title":"Engineering the intestinal lymphatic transport of oral nanoparticles to educate macrophages for cancer combined immunotherapy","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115304_b0035","doi-asserted-by":"crossref","first-page":"22213","DOI":"10.1021\/acsami.1c03709","article-title":"Lymph node delivery strategy enables the activation of cytotoxic T lymphocytes and natural killer cells to augment cancer immunotherapy","volume":"13","author":"Jiang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2024.115304_b0040","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1021\/acs.molpharmaceut.3c00409","article-title":"Human serum albumin nanoparticles as a carrier of 20(S)-protopanaxadiol via intramuscular injection to alleviate cyclophosphamide-induced myelosuppression","volume":"20","author":"Liu","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2024.115304_b0045","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.addr.2011.05.019","article-title":"Intestinal lymphatic transport for drug delivery","volume":"63","author":"Y\u00e1\u00f1ez","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41578-019-0110-7","article-title":"Material design for lymph node drug delivery","volume":"4","author":"Schudel","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1126\/science.aav9000","article-title":"A sweeter approach to vaccine design","volume":"363","author":"Wilson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.addr.2024.115304_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114097","article-title":"Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers","volume":"182","author":"Haddadzadegan","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113966","article-title":"Immunological perspectives on spatial and temporal vaccine delivery","volume":"178","author":"Zhu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0070","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.addr.2020.08.013","article-title":"Imaging technology of the lymphatic system","volume":"170","author":"Polomska","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2019.08.009","article-title":"Lymphatic changes in cancer and drug delivery to the lymphatics in solid tumors","volume":"144","author":"Cote","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0080","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1084\/jem.20062596","article-title":"Functionally specialized junctions between endothelial cells of lymphatic vessels","volume":"204","author":"Baluk","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2024.115304_b0085","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","article-title":"Lymphangiogenesis: molecular mechanisms and future promise","volume":"140","author":"Tammela","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.addr.2024.115304_b0090","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41577-020-0281-x","article-title":"Lymphatic endothelial cells of the lymph node","volume":"20","author":"Jalkanen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2024.115304_b0095","doi-asserted-by":"crossref","first-page":"12080","DOI":"10.1038\/s41598-017-11599-x","article-title":"Demonstration and analysis of the suction effect for pumping lymph from tissue beds at subatmospheric pressure","volume":"7","author":"Jamalian","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.addr.2024.115304_b0100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.addr.2020.06.003","article-title":"Dawn of lipid nanoparticles in lymph node targeting: potential in cancer immunotherapy","volume":"167","author":"Nakamura","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2004.11.013","article-title":"The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node","volume":"22","author":"Sixt","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2024.115304_b0110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.immuni.2014.12.024","article-title":"Strategically localized dendritic cells promote rapid T cell responses to lymph-borne particulate antigens","volume":"42","author":"Gerner","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2024.115304_b0115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nri3689","article-title":"Follicular dendritic cells: dynamic antigen libraries","volume":"14","author":"Heesters","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2024.115304_b0120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cell.2020.06.039","article-title":"The lymphatic vasculature in the 21st century: novel functional roles in homeostasis and disease","volume":"182","author":"Oliver","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.addr.2024.115304_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115130","article-title":"Nanocarriers transport across the gastrointestinal barriers: the contribution to oral bioavailability via blood circulation and lymphatic pathway","volume":"203","author":"Wang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0130","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1016\/j.apsb.2023.01.006","article-title":"Advanced subunit vaccine delivery technologies: from vaccine cascade obstacles to design strategies","volume":"13","author":"Hou","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2024.115304_b0135","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41568-019-0186-9","article-title":"Improving cancer immunotherapy through nanotechnology","volume":"19","author":"Goldberg","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.addr.2024.115304_b0140","doi-asserted-by":"crossref","first-page":"0030","DOI":"10.34133\/research.0030","article-title":"Delivery of biomimetic liposomes via meningeal lymphatic vessels route for targeted therapy of parkinson's disease","volume":"6","author":"Liu","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.addr.2024.115304_b0145","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.addr.2020.08.003","article-title":"Lipoprotein-based drug delivery","volume":"159","author":"Busatto","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2014.04.051","article-title":"Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers","volume":"193","author":"Ryan","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1015880819328","article-title":"Effect of molecular-weight on the lymphatic absorption of water-soluble compounds following subcutaneous administration","volume":"7","author":"Supersaxo","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2024.115304_b0160","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/acsnano.7b01261","article-title":"Impact of semiconducting perylene diimide nanoparticle size on lymph node mapping and cancer imaging","volume":"11","author":"Yang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115304_b0165","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/jps.21970","article-title":"Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery","volume":"99","author":"Rao","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2024.115304_b0170","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1021\/acs.accounts.0c00260","article-title":"Engineering strategies for lymph node targeted immune activation","volume":"53","author":"Chen","year":"2020","journal-title":"Accounts Chem. Res."},{"key":"10.1016\/j.addr.2024.115304_b0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jconrel.2011.07.034","article-title":"LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor","volume":"157","author":"Yan","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0180","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/bip.20978","article-title":"Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA","volume":"89","author":"Jiang","year":"2008","journal-title":"Biopolymers"},{"key":"10.1016\/j.addr.2024.115304_b0185","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cmet.2013.04.002","article-title":"Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL","volume":"17","author":"Lim","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.addr.2024.115304_b0190","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/vaccines10050684","article-title":"Antigen Targeting of porcine skin DEC205+ dendritic cells","volume":"10","author":"Melgoza-Gonz\u00e1lez","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.addr.2024.115304_b0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2022.10.006","article-title":"Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes","volume":"352","author":"Japiassu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113914","article-title":"Vaccine delivery systems toward lymph nodes","volume":"179","author":"Ding","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0205","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3390\/pharmaceutics13081200","article-title":"Focus on the lymphatic route to optimize drug delivery in cardiovascular medicine","volume":"13","author":"Tessier","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2024.115304_b0210","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41578-019-0156-6","article-title":"Materials for oral delivery of proteins and peptides","volume":"5","author":"Brown","year":"2020","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0215","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jconrel.2021.12.003","article-title":"Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport","volume":"341","author":"Elz","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0220","doi-asserted-by":"crossref","first-page":"1901810","DOI":"10.1002\/advs.201901810","article-title":"Efficient intestinal digestion and on site tumor-bioactivation are the two important determinants for chylomicron-mediated lymph-targeting triglyceride-mimetic docetaxel oral prodrugs","volume":"6","author":"Tian","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2024.115304_b0225","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.addr.2016.04.007","article-title":"50 years of oral lipid-based formulations: provenance, progress and future perspectives","volume":"101","author":"Feeney","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2020.07.034","article-title":"Bile acid transporter-mediated oral drug delivery","volume":"327","author":"Deng","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113928","article-title":"Advanced oral vaccine delivery strategies for improving the immunity adv","volume":"177","author":"Zhang","year":"2021","journal-title":"Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0240","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jconrel.2021.08.060","article-title":"Bile acid transporter-mediated oral absorption of insulin via hydrophobic ion-pairing approach","volume":"338","author":"Bashyal","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0245","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.apsb.2022.10.020","article-title":"The feasibility of oral targeted drug delivery: gut immune to particulates?","volume":"13","author":"Ren","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2024.115304_b0250","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.apsb.2020.12.022","article-title":"An update on oral drug delivery via intestinal lymphatic transport","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2024.115304_b0255","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2174\/1389450121666200609113252","article-title":"Present scenario of M-cell targeting ligands for oral mucosal immunization","volume":"21","author":"Saraf","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.addr.2024.115304_b0260","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202104139","article-title":"Engineering nano- and microparticles as oral delivery vehicles to promote intestinal lymphatic drug transport","volume":"33","author":"Miao","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0265","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2018.02.021","article-title":"Exploiting or overcoming the dome trap for enhanced oral immunization and drug delivery","volume":"275","author":"Qi","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0270","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/17425247.2023.2214362","article-title":"Role of nanotechnology in the prolonged release of drugs by the subcutaneous route","volume":"20","author":"Rama","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2024.115304_b0275","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40259-020-00465-4","article-title":"Immunogenicity challenges associated with subcutaneous delivery of therapeutic proteins","volume":"35","author":"Jarvi","year":"2021","journal-title":"BioDrugs"},{"key":"10.1016\/j.addr.2024.115304_b0280","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2014.03.011","article-title":"Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site","volume":"182","author":"Kinnunen","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0285","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1208\/s12248-012-9367-0","article-title":"Mechanistic determinants of biotherapeutics absorption following SC administration","volume":"14","author":"Richter","year":"2012","journal-title":"Aaps J."},{"key":"10.1016\/j.addr.2024.115304_b0290","first-page":"461","article-title":"Subcutaneous administration of biotherapeutics: current experience in animal models","volume":"12","author":"McDonald","year":"2010","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.addr.2024.115304_b0295","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s11095-012-0708-6","article-title":"Fluorescence imaging of the lymph node uptake of proteins in mice after subcutaneous injection: molecular weight dependence","volume":"29","author":"Wu","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2024.115304_b0300","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/17425247.2019.1568408","article-title":"Subcutaneous delivery of biotherapeutics: challenges at the injection site","volume":"16","author":"Sequeira","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2024.115304_b0305","first-page":"207","article-title":"Lymphatic vessel network structure and physiology","volume":"9","author":"Breslin","year":"2019","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.addr.2024.115304_b0310","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2020.07.046","article-title":"Lymphatic targeting by albumin-hitchhiking: applications and optimisation","volume":"327","author":"Abdallah","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0315","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202107960","article-title":"Nanocarriers for skin applications: where do we stand?","volume":"61","author":"Tiwari","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2024.115304_b0320","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.addr.2020.05.011","article-title":"Nanoparticles for topical drug delivery: potential for skin cancer treatment","volume":"153","author":"Krishnan","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0325","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2024.115304_b0330","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/1061186X.2019.1693579","article-title":"Nanomaterial and advanced technologies in transdermal drug delivery","volume":"28","author":"Rabiei","year":"2020","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2024.115304_b0335","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.addr.2019.10.004","article-title":"Intradermal and transdermal drug delivery using microneedles-fabrication, performance evaluation and application to lymphatic delivery","volume":"153","author":"Sabri","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0340","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.semcdb.2018.09.007","article-title":"Embryology, anatomy, physiology and pathophysiology of the peritoneum and the peritoneal vasculature","volume":"92","author":"Kastelein","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2024.115304_b0345","doi-asserted-by":"crossref","first-page":"11453","DOI":"10.1073\/pnas.1523141113","article-title":"Improved i.p. drug delivery with bioadhesive nanoparticles","volume":"113","author":"Deng","year":"2016","journal-title":"Proc. Natl. Acad. Sci. u. s. a."},{"key":"10.1016\/j.addr.2024.115304_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118456","article-title":"Therapeutic delivery to the peritoneal lymphatics: current understanding, potential treatment benefits and future prospects","volume":"567","author":"Sarfarazi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2024.115304_b0355","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1177\/15353702211010762","article-title":"Overcoming physiological barriers by nanoparticles for intravenous drug delivery to the lymph nodes","volume":"246","author":"Trac","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.addr.2024.115304_b0360","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.it.2022.07.002","article-title":"High endothelial venules as potential gateways for therapeutics","volume":"43","author":"Hussain","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2024.115304_b0365","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.celrep.2016.04.007","article-title":"Targeted delivery of immunomodulators to lymph nodes","volume":"15","author":"Azzi","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.addr.2024.115304_b0370","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1172\/JCI120923","article-title":"Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival","volume":"128","author":"Bahmani","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2024.115304_b0375","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/adma.202300812","article-title":"Nanotargeted delivery of immune therapeutics in type 1 diabetes","volume":"35","author":"Jung","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0380","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2009.08.005","article-title":"PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats","volume":"140","author":"Kaminskas","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0385","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1083\/jcb.100.2.418","article-title":"Endothelial fenestral diaphragms: a quick-freeze, deep-etch study","volume":"100","author":"Bearer","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2024.115304_b0390","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1084\/jem.20170335","article-title":"Dendritic cell and antigen dispersal landscapes regulate T cell immunity","volume":"214","author":"Gerner","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2024.115304_b0395","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0005-2736(97)00275-7","article-title":"Lymphatic uptake and biodistribution of liposomes after subcutaneous injection - IV. fate of liposomes in regional lymph nodes","volume":"1370","author":"Oussoren","year":"1998","journal-title":"Biochim. Biophys. Acta-Biomembr."},{"key":"10.1016\/j.addr.2024.115304_b0400","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108540119","article-title":"CD169+ macrophages in lymph node and spleen critically depend on dual RANK and LTbetaR signaling","volume":"119","author":"Camara","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2024.115304_b0405","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3298","article-title":"HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes","volume":"12","author":"Girard","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2024.115304_b0410","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1172\/JCI125740","article-title":"Transcytosis route mediates rapid delivery of intact antibodies to draining lymph nodes","volume":"129","author":"K\u00e4h\u00e4ri","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2024.115304_b0415","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41578-021-00372-2","article-title":"Designing spatial and temporal control of vaccine responses","volume":"7","author":"Roth","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0420","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jconrel.2023.09.049","article-title":"The biomolecular gastrointestinal corona in oral drug delivery","volume":"363","author":"Aljabbari","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0425","doi-asserted-by":"crossref","first-page":"201700409","DOI":"10.1002\/smll.201700409","article-title":"Protein corona: impact of lymph versus blood in a complex in vitro environment","volume":"13","author":"Bonvin","year":"2017","journal-title":"Small"},{"key":"10.1016\/j.addr.2024.115304_b0430","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/med.21767","article-title":"Protein corona formed in the gastrointestinal tract and its impacts on oral delivery of nanoparticles","volume":"41","author":"Zhang","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0435","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1021\/nn505015e","article-title":"Review of nanomaterials in dentistry: interactions with the oral microenvironment, clinical applications, hazards, and benefits","volume":"9","author":"Besinis","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115304_b0440","doi-asserted-by":"crossref","first-page":"21660","DOI":"10.1021\/acsami.7b04916","article-title":"Size-dependent translocation of nanoemulsions via oral delivery","volume":"9","author":"Xia","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2024.115304_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115044","article-title":"The interplay between PEGylated nanoparticles and blood immune system","volume":"200","author":"Guo","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0450","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1039\/C9BM00873J","article-title":"Slowing down lipolysis significantly enhances the oral absorption of intact solid lipid nanoparticles","volume":"7","author":"Yu","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2024.115304_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114635","article-title":"Protein corona: friend or foe? co-opting serum proteins for nanoparticle delivery","volume":"192","author":"Kim","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115116","article-title":"Nano-bio interactions in mRNA nanomedicine: challenges and opportunities for targeted mRNA delivery","volume":"203","author":"Saiding","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0465","doi-asserted-by":"crossref","first-page":"e1905740","DOI":"10.1002\/adma.201905740","article-title":"Built-in active microneedle patch with enhanced autonomous drug delivery","volume":"32","author":"Lopez-Ramirez","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0470","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1021\/acs.molpharmaceut.2c00507","article-title":"Evaluation of pharmacokinetics, biodistribution, and antimalarial efficacy of artemether-loaded polymeric nanorods","volume":"20","author":"Bhide","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2024.115304_b0475","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jconrel.2023.10.002","article-title":"Battle of the milky way: lymphatic targeted drug delivery for pathogen eradication","volume":"363","author":"Taheri","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0480","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12951-023-02022-x","article-title":"Advances in nanomedicines for lymphatic imaging and therapy","volume":"21","author":"He","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2024.115304_b0485","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2016.01.041","article-title":"The potential of protein-nanomaterial interaction for advanced drug delivery","volume":"225","author":"Peng","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114356","article-title":"The effects of protein corona on in vivo fate of nanocarriers","volume":"186","author":"Xiao","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0495","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature12978","article-title":"Structure-based programming of lymph-node targeting in molecular vaccines","volume":"507","author":"Liu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115304_b0500","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41467-017-02191-y","article-title":"Albumin\/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy","volume":"8","author":"Zhu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2024.115304_b0505","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12951-023-01991-3","article-title":"Cracking the intestinal lymphatic system window utilizing oral delivery vehicles for precise therapy","volume":"21","author":"Miao","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2024.115304_b0510","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.addr.2021.03.004","article-title":"Oral lipid nanomedicines: current status and future perspectives in cancer treatment","volume":"173","author":"El Moukhtari","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0515","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/j.apsb.2022.12.014","article-title":"Oral nano-formulation improves pancreatic islets dysfunction via lymphatic transport for antidiabetic treatment","volume":"13","author":"Hou","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2024.115304_b0520","article-title":"An engineered nanosugar enables rapid and sustained glucose-responsive insulin delivery in diabetic mice","volume":"35","author":"Xu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113833","article-title":"Physiological models for in vivo imaging and targeting the lymphatic system: nanoparticles and extracellular vesicles","volume":"175","author":"Olmeda","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0530","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.addr.2020.10.004","article-title":"Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy","volume":"160","author":"Manspeaker","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0535","article-title":"Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2024.115304_b0540","doi-asserted-by":"crossref","first-page":"13044","DOI":"10.1021\/acsnano.3c02403","article-title":"Mechanisms of nanoparticle transport across intestinal tissue: an oral delivery perspective","volume":"17","author":"Ejazi","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115304_b0545","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biomaterials.2018.10.012","article-title":"Chylomicron-pretended nano-bio self-assembling vehicle to promote lymphatic transport and GALTs target of oral drugs","volume":"188","author":"Mao","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115304_b0550","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1021\/acs.molpharmaceut.0c00764","article-title":"Selected factors affecting oral bioavailability of nanoparticles surface-conjugated with glycocholic acid via intestinal lymphatic pathway","volume":"17","author":"Kim","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2024.115304_b0555","article-title":"Macrophage-hitchhiked orally administered \u03b2-glucans-functionalized nanoparticles as \u201cprecision-guided stealth missiles\u201c for targeted pancreatic cancer therapy","volume":"35","author":"Chen","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0560","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2021.05.017","article-title":"Oral delivery of topotecan in polymeric nanoparticles: lymphatic distribution and pharmacokinetics","volume":"335","author":"Jeong","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0565","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1021\/acs.molpharmaceut.8b00708","article-title":"Immense insulin intestinal uptake and lymphatic transport using bile acid conjugated partially uncapped liposome","volume":"15","author":"Kim","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2024.115304_b0570","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41551-021-00791-0","article-title":"Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin","volume":"5","author":"Lee","year":"2021","journal-title":"Nat. Biomed. Eng"},{"key":"10.1016\/j.addr.2024.115304_b0575","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jconrel.2020.10.036","article-title":"Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach","volume":"329","author":"Qin","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0580","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202100701","article-title":"A noninvasive gut-to-brain oral drug delivery system for treating brain tumors","volume":"33","author":"Miao","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120944","article-title":"Effective oral delivery of exenatide-Zn2+complex through distal ileum-targeted double layers nanocarriers modified with deoxycholic acid and glycocholic acid in diabetes therapy","volume":"275","author":"Han","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115304_b0590","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12951-023-02011-0","article-title":"New trends in brain tumor immunity with the opportunities of lymph nodes targeted drug delivery","volume":"21","author":"Qi","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2024.115304_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114322","article-title":"Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery","volume":"186","author":"Klepach","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0600","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2022.11.036","article-title":"siRNA delivery to lymphatic endothelial cells via ApoE-mediated uptake by lipid nanoparticles","volume":"353","author":"Sakurai","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0605","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2013.08.004","article-title":"PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin","volume":"172","author":"Ryan","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0610","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1080\/10717544.2021.1968978","article-title":"Immunosuppressive effect of PLGA-FK506-NPs in treatment of acute cardiac rejection via topical subcutaneous injection","volume":"28","author":"Deng","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2024.115304_b0615","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/acs.nanolett.0c01713","article-title":"Zwitterionic nanoconjugate enables safe and efficient lymphatic drug delivery","volume":"20","author":"Li","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2024.115304_b0620","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1021\/acs.molpharmaceut.0c00348","article-title":"High-density lipoprotein composition influences lymphatic transport after subcutaneous administration","volume":"17","author":"Gracia","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2024.115304_b0625","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1021\/acs.nanolett.0c01806","article-title":"Therapeutic delivery to the brain via the lymphatic vasculature","volume":"20","author":"Zhao","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2024.115304_b0630","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12951-023-01775-9","article-title":"Customizing delivery nano-vehicles for precise brain tumor therapy","volume":"21","author":"Miao","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2024.115304_b0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114862","article-title":"Long-acting parenteral drug delivery systems for the treatment of chronic diseases","volume":"198","author":"Jindal","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0640","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.addr.2016.02.003","article-title":"Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: insights for applications in HIV therapy","volume":"103","author":"Owen","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0645","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2020.05.022","article-title":"Recent advances in long-acting nanoformulations for delivery of antiretroviral drugs","volume":"324","author":"Surve","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0650","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01529-09","article-title":"Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable Antiretroviral formulation","volume":"54","author":"van 't Klooster","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2024.115304_b0655","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2019.10.004","article-title":"Solid lipid nanoparticle-based dissolving microneedles: a promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis","volume":"316","author":"Permana","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0660","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2022.05.045","article-title":"Dissolving microneedles: applications and growing therapeutic potential","volume":"348","author":"Sartawi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0665","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1039\/C4CC08746A","article-title":"Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy","volume":"51","author":"Kong","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2024.115304_b0670","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1021\/acs.molpharmaceut.9b00855","article-title":"Lymphatic uptake of liposomes after intraperitoneal administration primarily occurs via the diaphragmatic lymphatics and is dependent on liposome surface properties","volume":"16","author":"Lee","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2024.115304_b0675","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jconrel.2021.12.004","article-title":"I.p.-injected cationic liposomes are retained and accumulate in peritoneally disseminated tumors","volume":"341","author":"Ando-Matsuoka","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0680","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1021\/acs.molpharmaceut.0c00226","article-title":"Targeting pro-tumoral macrophages in early primary and metastatic breast tumors with the CD206-binding mUNO peptide","volume":"17","author":"Lepland","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2024.115304_b0685","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.biomaterials.2017.07.035","article-title":"Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis","volume":"143","author":"Dou","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2024.115304_b0690","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ijbiomac.2021.09.161","article-title":"Systematic comparisons of dissolving and swelling hyaluronic acid microneedles in transdermal drug delivery","volume":"191","author":"Yu","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2024.115304_b0695","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nature02238","article-title":"T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases","volume":"427","author":"Mempel","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.addr.2024.115304_b0700","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2024.115304_b0705","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1039\/C7CS00536A","article-title":"Molecular engineering solutions for therapeutic peptide delivery","volume":"46","author":"Acar","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0710","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.addr.2019.09.005","article-title":"Physical and chemical profiles of nanoparticles for lymphatic targeting","volume":"151","author":"Ke","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0715","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2024.115304_b0720","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1021\/acs.molpharmaceut.9b01182","article-title":"The effect of size and charge of lipid nanoparticles prepared by microfluidic mixing on their lymph node transitivity and distribution","volume":"17","author":"Nakamura","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2024.115304_b0725","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2011.12.017","article-title":"PEGylated cationic liposomes robustly augment vaccine-induced immune responses: role of lymphatic trafficking and biodistribution","volume":"159","author":"Zhuang","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2024.115304_b0730","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41565-019-0512-0","article-title":"Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators","volume":"14","author":"Conniot","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2024.115304_b0735","article-title":"Chiral-selective antigen-presentation by supramolecular chiral polymer micelles","volume":"35","author":"Jiang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114990","article-title":"Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications","volume":"200","author":"Jeong","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0745","doi-asserted-by":"crossref","first-page":"e2202688","DOI":"10.1002\/adhm.202202688","article-title":"Polymer-based mRNA delivery strategies for advanced therapies","volume":"12","author":"Yang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0750","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41563-023-01472-w","article-title":"Hydrogels for RNA delivery","volume":"22","author":"Zhong","year":"2023","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0755","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201895","article-title":"Responsive multivesicular polymeric nanovaccines that codeliver STING agonists and neoantigens for combination tumor immunotherapy","volume":"9","author":"Su","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2024.115304_b0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114107","article-title":"Nanovaccines with cell-derived components for cancer immunotherapy","volume":"182","author":"Meng","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0765","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302423","article-title":"Dendritic cell-mimicking nanoparticles promote mRNA delivery to lymphoid organs","author":"Cao","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2024.115304_b0770","doi-asserted-by":"crossref","first-page":"13168","DOI":"10.1021\/acsnano.2c06300","article-title":"Nanocarrier co-formulation for delivery of a TLR7 agonist plus an immunogenic cell death stimulus triggers effective pancreatic cancer chemo-immunotherapy","volume":"16","author":"Luo","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115304_b0775","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1021\/acsnano.0c02765","article-title":"Co-delivery of peptide neoantigens and stimulator of interferon genes agonists enhances response to cancer vaccines","volume":"14","author":"Shae","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115304_b0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101244","article-title":"Recombinant cancer nanovaccine for targeting tumor-associated macrophage and remodeling tumor microenvironment","volume":"40","author":"Tang","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2024.115304_b0785","doi-asserted-by":"crossref","first-page":"33532","DOI":"10.1021\/acsami.8b10081","article-title":"Immune adjuvant targeting micelles allow efficient dendritic cell migration to lymph nodes for enhanced cellular immunity","volume":"10","author":"Yang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.addr.2024.115304_b0790","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","article-title":"Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospects","volume":"20","author":"Kon","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.addr.2024.115304_b0795","first-page":"28","article-title":"Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA","author":"Li","year":"2023","journal-title":"Nat. Biomed. Eng"},{"key":"10.1016\/j.addr.2024.115304_b0800","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41591-022-02061-1","article-title":"The landscape of mRNA nanomedicine","volume":"28","author":"Huang","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2024.115304_b0805","doi-asserted-by":"crossref","first-page":"2303261","DOI":"10.1002\/adma.202303261","article-title":"Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0810","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1021\/nn502975r","article-title":"Nanogel-based immunologically stealth vaccine targets macrophages in the medulla of lymph node and induces potent antitumor immunity","volume":"8","author":"Muraoka","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115304_b0815","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41565-020-00790-3","article-title":"Eliciting B cell immunity against infectious diseases using nanovaccines","volume":"16","author":"Singh","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2024.115304_b0820","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.aat9120","article-title":"Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers","volume":"363","author":"Tokatlian","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.addr.2024.115304_b0825","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1021\/acs.nanolett.9b02834","article-title":"Nanoparticle size influences antigen retention and presentation in lymph node follicles for humoral immunity","volume":"19","author":"Zhang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2024.115304_b0830","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf1152","article-title":"A particulate saponin\/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity","volume":"6","author":"Silva","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.addr.2024.115304_b0835","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41591-020-0753-3","article-title":"Engineered immunogen binding to alum adjuvant enhances humoral immunity","volume":"26","author":"Moyer","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2024.115304_b0840","doi-asserted-by":"crossref","first-page":"e2006007","DOI":"10.1002\/adma.202006007","article-title":"Development of a cancer vaccine using in vivo click-chemistry-mediated active lymph node accumulation for improved immunotherapy","volume":"33","author":"Qin","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2024.115304_b0845","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2024.115304_b0850","doi-asserted-by":"crossref","first-page":"15231","DOI":"10.1021\/acsnano.2c12584","article-title":"The mRNA vaccine revolution: COVID-19 has launched the future of vaccinology","volume":"17","author":"Ye","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2024.115304_b0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114417","article-title":"Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines","volume":"188","author":"Nakamura","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114021","article-title":"Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome","volume":"179","author":"Lee","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2024.115304_b0865","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","article-title":"Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges","volume":"17","author":"Martin","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X24001261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X24001261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T12:14:22Z","timestamp":1716120862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X24001261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":173,"alternative-id":["S0169409X24001261"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2024.115304","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2024.115304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115304"}}